César de la Fuente, Ph.D. is a Presidential Assistant Professor at the University of Pennsylvania, where he is leading the Machine Biology Group to integrate synthetic biology, automation, computer science, and AI. Prof. de la Fuente is pioneering the computerization of biological systems, seeking to expand nature’s repertoire to build novel synthetic molecular tools and devise therapies that nature has not previously discovered.
The Machine Biology Group aims to develop computer-made tools and medicines that will replenish our current antibiotic arsenal. Prof. de la Fuente was named a Boston Latino 30 Under 30, a 2018 Wunderkind by STAT News, a Top 10 Under 40 of 2019 by GEN, a Top 10 MIT Technology Review Innovator Under 35 (Spain), and is a recipient of the 2019 Society of Hispanic Professional Engineers Young Investigator Award.
He has also been recognized by MIT Technology Review in 2019 as one of the world’s top innovators for “digitizing evolution to make better antibiotics”. His scientific discoveries have yielded over 70 peer-reviewed publications and multiple patents. Prof. de la Fuente aims to develop the world’s first computer-made tools and medicines.